Michell Ann Cadiz, FNP

Michell Cadiz practices at USC Norris Cancer Hospital in Los Angeles, California.

Michell Cadiz's NPI, 1194161554, was assigned on May 13, 2013. Michell Cadiz holds California license 23013.

Michell Cadiz's primary practice is USC Norris Cancer Hospital, at 1441 Eastlake Ave, Los Angeles, CA.

Michell Cadiz's primary practice is USC Norris Cancer Hospital in Los Angeles, California. Michell Cadiz is also affiliated with Keck Hospital of USC. The medical group on file is USC Care Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Michell Cadiz practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Michell Cadiz's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Michell Cadiz is licensed in California.

CMS data shows 14 Medicare services from Michell Cadiz across 1 procedure code in 2024, all of them office visits, for 19 Medicare patients. Medicare paid $606 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 19 Medicare patients who saw Michell Cadiz in 2024. 75% of them have high blood pressure, and 74% have arthritis. Their average risk score is 3.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michell Cadiz's median patient age at 66, with 48% women.

In 2024, Michell Cadiz wrote 379 Medicare Part D claims for 74 patients. 72% of them were for generic drugs. CMS names the drug for 213 of them, across 11 drugs with 11 or more claims each, at $1,140,286 in total drug cost.

Michell Cadiz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 195 general payments to Michell Cadiz from 29 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 75% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,460.